BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
2
Barbora Lubyova, Jan Hodek, Ales Zabransky, Hana Prouzova, Martin Hubalek, Ivan Hirsch, Jan Weber, Haitao Guo. PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV corePLOS ONE 2017; 12(10): e0186982 doi: 10.1371/journal.pone.0186982
3
Yinghua Zhang, Chuanfang Wang, Hui Li, Yuanyuan Ding. Decreased liver stiffness by transient elastography indicates lower incidence of hepatocellular carcinoma in patients with chronic hepatitis BMedicine 2019; 98(3): e13929 doi: 10.1097/MD.0000000000013929
4
Isabelle Beaudry-Bellefeuille, Alison Lane, Simon Chiu, Christopher Oldmeadow, Eduardo Ramos Polo, Shelly J Lane. The Toileting Habit Profile Questionnaire-Revised: Examining Discriminative and Concurrent ValidityJournal of Occupational Therapy, Schools, & Early Intervention 2019; 12(3): 311 doi: 10.1080/19411243.2019.1590756
5
Ahmed Wahid, Mustafa A. Hamzawy, Mohamad M. A. Khalifa, Gamal F. M. Gad, Amany Bekhit, Sayed F. Abdelwahab. RNA protein kinase SNP at −226 C<T is a biomarker for the clearance of HCV among Egyptian patientsImmunological Investigations 2019; 48(3): 211 doi: 10.1080/08820139.2018.1493496
6
Yuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Hiroko Shindo, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Taisuke Inoue, Tadashi Sato, Minoru Sakamoto, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto. Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinomaHepatology Research 2019; 49(1): 51 doi: 10.1111/hepr.13277
7
An K Le, Hwai-I Yang, Ming-Lun Yeh, Mingjuan Jin, Huy N Trinh, Linda Henry, Anne Liu, Jian Q Zhang, Jiayi Li, Christopher Wong, Clifford Wong, Ramsey Cheung, Ming-Lung Yu, Mindie H Nguyen. Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis BThe Journal of Infectious Diseases 2020;  doi: 10.1093/infdis/jiaa330
8
Mayuko Nishi, Kei Miyakawa, Satoko Matsunaga, Hajera Khatun, Yutaro Yamaoka, Koichi Watashi, Masaya Sugiyama, Hirokazu Kimura, Takaji Wakita, Akihide Ryo. Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core ProteinFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00026
9
Grace Lai-Hung Wong. Liver Elastography2020; : 375 doi: 10.1007/978-3-030-40542-7_34
10
Tung-Hung Su, Jia-Horng Kao. Unmet Needs in Clinical and Basic Hepatitis B Virus ResearchThe Journal of Infectious Diseases 2017; 216(suppl_8): S750 doi: 10.1093/infdis/jix382
11
Aftab Ahmed, Farhan Saeed, Muhammad Umair Arshad, Muhammad Afzaal, Ali Imran, Shinawar Waseem Ali, Bushra Niaz, Awais Ahmad, Muhammad Imran. Impact of intermittent fasting on human health: an extended review of metabolic cascadesInternational Journal of Food Properties 2018; 21(1): 2700 doi: 10.1080/10942912.2018.1560312
12
Luca Rinaldi, Antonio Ascione, Vincenzo Messina, Valerio Rosato, Giovanna Valente, Vincenzo Sangiovanni, Rosa Zampino, Aldo Marrone, Luca Fontanella, Nicolina de Rosa, Pasquale Orabona, Carmela Buonomo, Antonio Chirianni, Luigi Elio Adinolfi, Guido Piai. Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitisInfection 2018; 46(2): 231 doi: 10.1007/s15010-017-1113-1
13
Patrick Kennedy, Samuel Litwin, Grace Dolman, Antonio Bertoletti, William Mason. Immune Tolerant Chronic Hepatitis B: The Unrecognized RisksViruses 2017; 9(5): 96 doi: 10.3390/v9050096
14
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
15
Tony Stankus. Reviews of Science for Science Librarians: Low-FODMAP Diets for Irritable Bowel Syndrome and Related DisordersScience & Technology Libraries 2019; 38(3): 243 doi: 10.1080/0194262X.2019.1617226
16
Derek J. Erstad, Bryan C. Fuchs, Kenneth K. Tanabe. Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapyCancer 2018; 124(15): 3084 doi: 10.1002/cncr.31257
17
Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis BClinical and Molecular Hepatology 2019; 25(4): 390 doi: 10.3350/cmh.2018.0103
18
Jung Woo Shin, Joonho Jeong, Seok Won Jung, Seung Bum Lee, Bo Ryung Park, Min-Ju Kim, Eun Ji Park, Neung Hwa Park. Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or TenofovirDigestive Diseases and Sciences 2020;  doi: 10.1007/s10620-020-06375-3
19
Yeon Seok Seo, Byoung Kuk Jang, Soon Ho Um, Jae Seok Hwang, Kwang-Hyub Han, Sang Gyune Kim, Kwan Sik Lee, Seung Up Kim, Young Seok Kim, Jung Il Lee. Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort studyOncotarget 2017; 8(68): 113213 doi: 10.18632/oncotarget.22375
20
Ching-Chung Lin, Ming-Jong Bair, Chia-Yuan Liu, Ze-Yu Lin, Chih-Jen Chen, Ming-Jen Chen, Cheng-Hsin Chu, Horng-Yuan Wang, Shou-Chuan Shih, Tsang-En Wang. High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogsMedicine 2019; 98(1): e13818 doi: 10.1097/MD.0000000000013818
21
Xiang Cui, Xiaoyan Jiang, Chunshan Wei, Yufeng Xing, Guangdong Tong. Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axisEnvironmental Toxicology and Pharmacology 2020; 78: 103397 doi: 10.1016/j.etap.2020.103397